Project Grant K01AR084466

Award Date 7/20/24
Completion Date 6/30/29
Dollars Obligated $139K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Salt Lake City, UT 84112, USA
Similar Awards
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, provides $488,782 to conduct research on the use of neuromuscular electrical stimulation (NMES) to address quadriceps weakness and atrophy following anterior cruciate ligament (ACL) injury and reconstruction. The overarching objective is to establish the mechanistic basis for how NMES can mitigate the...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $549,437 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant, effective September 1, 2024 through June 30, 2029, aims to develop a novel therapy that leverages the Hedgehog signaling pathway to improve tendon-to-bone...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $1,197,166 to Rhode Island Hospital to evaluate a neuromuscular mechanism that may explain differences in functional outcomes between two anterior cruciate ligament (ACL) surgery procedures. The overarching objective is to leverage patients enrolled in the BEAR-MOON clinical trial...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $1,727,423.00 to the University of Iowa over 5 years starting August 7, 2024. The purpose of this research is to investigate the role of the myokine FGF21 in the progression of skeletal abnormalities associated with Duchenne muscular dystrophy (DMD). The project aims to identify the...
This federal Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $520,154 to Arcadia University to conduct research on improving quadriceps muscle function and reducing the risk of post-traumatic osteoarthritis in individuals recovering from anterior cruciate ligament (ACL) reconstruction surgery. The key objectives of the project are to: 1) Determine if non-invasive brain...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research federal grant program (CFDA 93.846), provides $147,236 to the University of Pittsburgh to quantify the mechanical effects of knee bracing and develop computational models to predict its ability to prevent ligamentous injuries such as medial collateral ligament (MCL) and anterior cruciate ligament (ACL) injuries. The...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $458,907 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to the University of Kentucky Research Foundation. The grant, effective February 1, 2025 through January 31, 2030, will support research to determine if the gut microbiome of exercise-trained mice can be used to attenuate skeletal muscle atrophy. Specifically, the project aims to investigate if...
This Project Grant award of $678,213 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) will fund research conducted by the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University to evaluate the impact of over-constraint of the patella following medial patellofemoral ligament (MPFL) reconstruction as a contributing factor to progressive cartilage...
This Project Grant award of $473,377 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, supports research to modulate the stem cell niche and improve skeletal muscle regeneration. The key objectives are to: Interrogate how muscle cells arise and develop functional characteristics from human pluripotent stem cells (hPSCs) through analysis of myogenic commitment factors and inhibition of...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, totaling $820,142, will support research into the influence of early-life physical inactivity on adult muscle quality and function. The project aims to 1) investigate the effect of early-life physical inactivity in mice on muscle quality and function in adulthood, 2) determine the impact on the...

This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will provide $139,050 in funding to the University of Utah over a five-year period from July 2024 to June 2029.

The purpose of this award is to support the research of Dr. Stephan Bodkin, an assistant professor at the University of Utah, in investigating the influence of anterior cruciate ligament (ACL) reconstruction on skeletal muscle remodeling and the development of intramuscular adipose tissue. Specifically, the project will quantify changes in intramuscular adipose tissue and intramyocellular lipids before and after ACL reconstruction, and evaluate the relationship between these measures of muscle adiposity and quadriceps muscle strength in both young and middle-aged adults. The findings from this research are expected to provide insights into the physiological contributors to muscle weakness following ACL injury and reconstruction, which could inform the development of more effective rehabilitation interventions.

Generated 7/1/25, 1:59 AM